Bibliographic Info
GuidelineAntiretroviral therapy of HIV infection in infants and children: towards universal access: recommendations for a public health approach 2010 revision
Year of Publication2010
Issuing InstitutionWHO
Recommendation
Status
Updated
Recommended in favor
Strong
Certainty of evidence
Low
After failure on a first-line regimen of zidovudine (AZT) or stavudine (d4T) + lamivudine (3TC), abacavir (ABC) + 3TC is the preferred nucleoside reverse transcriptase inhibitor (NRTI) backbone option for second-line ART; ABC + ddI is an alternative